Biochemical Engineering Special Interest Group
biological engineering professionals
20 July 2017

GSK to sell Ulverston and cancel biopharm plant

GSK has halted plans for a biopharmaceutical manufacturing facility in Cumbria, UK, which was expected to cost 350 million pounds. The company indicates it no longer needs the manufacturing capacity. It is also considering selling its antibiotics business located at Ulverston, UK. That facility makes antibiotics such as Zinnat, Zinacef and Fortum. Source: Biospace 20/7/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).